Increased NAALADL2 and TBL1XR1 expression have previously been linked to poor prognosis in cancers leading us to examine the frequency of somatic copy-number gains in these genes across various prostate cancer subtypes19–21,26. This evidence concerns the gene NAALADL2 and prostate carcinoma.